JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
-4.8%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$2.35B
AUM Growth
+$754M
(+47%)
Cap. Flow
+$829M
Cap. Flow
% of AUM
35.33%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
2,090
New
757
Increased
387
Reduced
353
Closed
592
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$294M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$26M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$25.9M |
| 4 |
CME Group
CME
|
+$18.7M |
| 5 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$17.9M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$82.9M |
| 2 |
iShares Silver Trust
SLV
|
+$13.5M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$11.1M |
| 4 |
Apple
AAPL
|
+$9.63M |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$7.81M |
Sector Composition
| 1 | Technology | 12.8% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Healthcare | 9.14% |
| 4 | Financials | 8.78% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Nektar Therapeutics
NKTR
$916M
| $181K | 0.01% |
+2,243
| New | +$181K |
|
1327
Barnes & Noble Education
BNED
$288M
| $179K | 0.01% |
501
+266
| +113% | +$95K |
|
1328
Forestar Group
FOR
$1.4B
| $179K | 0.01% |
+10,100
| New | +$179K |
|
|
GAN
1329
DELISTED
GAN Ltd
GAN
| $179K | 0.01% |
37,100
-9,200
| -20% | -$44.4K |
|
|
ONL
1330
Orion Office REIT
ONL
$165M
| $178K | 0.01% |
+12,689
| New | +$178K |
|
1331
Capitol Federal Financial
CFFN
$840M
| $177K | 0.01% |
+16,300
| New | +$177K |
|
1332
Vera Bradley
VRA
$63.7M
| $177K | 0.01% |
+23,100
| New | +$177K |
|
|
GRTS
1333
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $175K | 0.01% |
+42,400
| New | +$175K |
|
1334
Viant Technology
DSP
$159M
| $174K | 0.01% |
26,568
+11,668
| +78% | +$76.4K |
|
|
FRBK
1335
DELISTED
Republic First Bancorp Inc
FRBK
| $174K | 0.01% |
+33,700
| New | +$174K |
|
|
AFMD
1336
DELISTED
Affimed
AFMD
| $173K | 0.01% |
3,950
+2,830
| +253% | +$124K |
|
1337
Purple Innovation
PRPL
$116M
| $172K | 0.01% |
+29,381
| New | +$172K |
|
1338
Arbutus Biopharma
ABUS
$886M
| $171K | 0.01% |
57,300
-18,340
| -24% | -$54.7K |
|
1339
Amplify Energy
AMPY
$161M
| $170K | 0.01% |
30,977
-13,923
| -31% | -$76.4K |
|
1340
Vertex
VERX
$3.81B
| $170K | 0.01% |
11,090
-1,710
| -13% | -$26.2K |
|
1341
Arhaus
ARHS
$1.56B
| $168K | 0.01% |
+19,700
| New | +$168K |
|
1342
Viking Therapeutics
VKTX
$2.91B
| $168K | 0.01% |
+55,883
| New | +$168K |
|
1343
CytomX Therapeutics
CTMX
$341M
| $168K | 0.01% |
+62,800
| New | +$168K |
|
1344
Scholar Rock
SRRK
$3B
| $168K | 0.01% |
+13,000
| New | +$168K |
|
1345
Heron Therapeutics
HRTX
$195M
| $167K | 0.01% |
+29,161
| New | +$167K |
|
1346
Axogen
AXGN
$739M
| $164K | 0.01% |
20,700
-18,100
| -47% | -$143K |
|
1347
ClearPoint Neuro
CLPT
$299M
| $164K | 0.01% |
15,800
-5,600
| -26% | -$58.1K |
|
1348
Olema Pharmaceuticals
OLMA
$536M
| $164K | 0.01% |
38,500
+24,338
| +172% | +$104K |
|
|
SCPL
1349
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $164K | 0.01% |
+12,700
| New | +$164K |
|
|
NAGE
1350
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $162K | 0.01% |
65,700
+26,800
| +69% | +$66.1K |
|